EUVIMEDEUVIMED entdecken
Crossref

Novel anti-HBV activities of myristicin and isoimperatorin, isolated from Petroselinum crispum

Sarfaraz Ahmed, Sakina Niyazi, Mohammad K. Parvez, Mohammed S. Al-Dosari, Mazin A. S. Abdelwahid, Omer I. Fantoukh, Mohammad Nur-e-Alam, Hattan A. Alharbi

Bulletin of the Chemical Society of Ethiopia · 24.03.2026 · 40 (6) · 1231-1241

DOI: 10.4314/bcse.v40i6.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of the Chemical Society of Ethiopia, online erschienen am 24.03.2026. Verfasst von Sarfaraz Ahmed und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver diseases, such as cirrhosis and carcinoma caused by the hepatitis B virus (HBV), remain an important global health issue. Despite availabilities of efficacious nucleoside analogs-based drugs, the emergence of HBV polymerase mutations associated with drug resistance restrict their clinical use. Therefore, phytochemicals have been reported for promising anti-HBV activities in vitro or in vivo. In this study, we have assessed the anti-HBV potential of myristicin and isoimperatorin, isolated from the n-hexane extract of Petroselinum crispum and characterized by NMR spectroscopy. Both compounds (6.25-50.0 µg/mL) pre-tested for their non-hepatocytotoxicity in cultured HepG2.2.15 cells, were subjected to anti-HBV assays using HBsAg and HBeAg ELISA kits. At the selected optimal-active dose (12.5 µg/mL), the compounds showed dose- and time-dependent activities in relation to the untreated control at day 5. Therein, while Myristicin moderately inhibited HBsAg (~38.2%) and HBeAg (~36.6%), isoimperatorin strongly suppressed HBsAg (~60.2%) and HBeAg (58.9%) close to those of Quercetin (standard). Further molecular docking analysis of isoimperatorin with HBV polymerase revealed high docking score (-8.6 kcal/mol) comparable to lamivudine (standard), suggesting its anti-HBV effect through blocking the polymerase enzymatic activity. In conclusion, to our best knowledge, we demonstrate significantly strong anti-HBV efficacy of isoimperatorin, warranting its further pre-clinical studies. KEY WORDS: Petroselinum crispum, Myristicin, Isoimperatorin, Hepatitis B virus, Anti-HBV activity, HepG2.2.15 cells, Molecular docking Bull. Chem. Soc. Ethiop. 2026, 40(6), 1231-1241. DOI: https://dx.doi.org/10.4314/bcse.v40i6.5

Zitieren

APA

Ahmed, S., Niyazi, S., Parvez, M. K., Al-Dosari, M. S., Abdelwahid, M. A. S., Fantoukh, O. I., Nur-e-Alam, M., & Alharbi, H. A. (2026). Novel anti-HBV activities of myristicin and isoimperatorin, isolated from Petroselinum crispum. Bulletin of the Chemical Society of Ethiopia, 40(6), 1231-1241. https://doi.org/10.4314/bcse.v40i6.5

Vancouver

Ahmed S, Niyazi S, Parvez MK, Al-Dosari MS, Abdelwahid MAS, Fantoukh OI, et al. Novel anti-HBV activities of myristicin and isoimperatorin, isolated from Petroselinum crispum. Bulletin of the Chemical Society of Ethiopia. 2026;40(6):1231-1241. doi:10.4314/bcse.v40i6.5

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Sarfaraz and Niyazi, Sakina and Parvez, Mohammad K. and Al-Dosari, Mohammed S. and Abdelwahid, Mazin A. S. and Fantoukh, Omer I. and Nur-e-Alam, Mohammad and Alharbi, Hattan A.},
  title = {Novel anti-HBV activities of myristicin and isoimperatorin, isolated from Petroselinum crispum},
  journal = {Bulletin of the Chemical Society of Ethiopia},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {1231--1241},
  doi = {10.4314/bcse.v40i6.5}
}
Kostenlos starten →